BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22532569)

  • 1. Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals.
    Nishimori H; Ehata S; Suzuki HI; Katsuno Y; Miyazono K
    J Biol Chem; 2012 Jun; 287(24):20037-46. PubMed ID: 22532569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoblast-secreted collagen upregulates paracrine Sonic hedgehog signaling by prostate cancer cells and enhances osteoblast differentiation.
    Zunich SM; Valdovinos M; Douglas T; Walterhouse D; Iannaccone P; Lamm ML
    Mol Cancer; 2012 Jul; 11():30. PubMed ID: 22559324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
    Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
    J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.
    Kitagawa Y; Dai J; Zhang J; Keller JM; Nor J; Yao Z; Keller ET
    Cancer Res; 2005 Dec; 65(23):10921-9. PubMed ID: 16322239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.
    Dai J; Keller J; Zhang J; Lu Y; Yao Z; Keller ET
    Cancer Res; 2005 Sep; 65(18):8274-85. PubMed ID: 16166304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal adhesion kinase activity is required for bone morphogenetic protein--Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells.
    Tamura Y; Takeuchi Y; Suzawa M; Fukumoto S; Kato M; Miyazono K; Fujita T
    J Bone Miner Res; 2001 Oct; 16(10):1772-9. PubMed ID: 11585340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine sonic hedgehog signalling by prostate cancer cells induces osteoblast differentiation.
    Zunich SM; Douglas T; Valdovinos M; Chang T; Bushman W; Walterhouse D; Iannaccone P; Lamm ML
    Mol Cancer; 2009 Mar; 8():12. PubMed ID: 19254376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of BMPs/Smad signaling pathway in mechanical response in osteoblasts.
    Wang L; Zhang X; Guo Y; Chen X; Li R; Liu L; Shi C; Guo C; Zhang Y
    Cell Physiol Biochem; 2010; 26(6):1093-102. PubMed ID: 21220940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein.
    Dai J; Kitagawa Y; Zhang J; Yao Z; Mizokami A; Cheng S; Nör J; McCauley LK; Taichman RS; Keller ET
    Cancer Res; 2004 Feb; 64(3):994-9. PubMed ID: 14871830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro.
    Lin DL; Tarnowski CP; Zhang J; Dai J; Rohn E; Patel AH; Morris MD; Keller ET
    Prostate; 2001 May; 47(3):212-21. PubMed ID: 11351351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGFβ1-Endo180-dependent collagen deposition is dysregulated at the tumour-stromal interface in bone metastasis.
    Caley MP; Kogianni G; Adamarek A; Gronau JH; Rodriguez-Teja M; Fonseca AV; Mauri F; Sandison A; Rhim JS; Pchejetski D; Palmieri C; Cobb JP; Waxman J; Sturge J
    J Pathol; 2012 Apr; 226(5):775-83. PubMed ID: 22072289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2.
    Katsuyama T; Otsuka F; Terasaka T; Inagaki K; Takano-Narazaki M; Matsumoto Y; Sada KE; Makino H
    Peptides; 2015 Nov; 73():88-94. PubMed ID: 26409788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of Smad1 transcriptional activity by Ras-extracellular signal-regulated kinase pathway: a possible mechanism for collagen-dependent osteoblastic differentiation.
    Suzawa M; Tamura Y; Fukumoto S; Miyazono K; Fujita T; Kato S; Takeuchi Y
    J Bone Miner Res; 2002 Feb; 17(2):240-8. PubMed ID: 11811554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of Shh and BMP paracrine signaling in a prostate cancer xenograft.
    Shaw A; Gipp J; Bushman W
    Differentiation; 2010 Jan; 79(1):41-7. PubMed ID: 19773112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.
    Li X; Sterling JA; Fan KH; Vessella RL; Shyr Y; Hayward SW; Matrisian LM; Bhowmick NA
    Mol Cancer Res; 2012 Apr; 10(4):494-503. PubMed ID: 22290877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro - evaluation towards understanding breast cancer cell bone metastasis.
    Du WW; Fang L; Yang W; Sheng W; Zhang Y; Seth A; Yang BB; Yee AJ
    BMC Cancer; 2012 Aug; 12():341. PubMed ID: 22862967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment.
    Koeneman KS; Yeung F; Chung LW
    Prostate; 1999 Jun; 39(4):246-61. PubMed ID: 10344214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of adenosine monophosphate-activated protein kinase suppresses bone morphogenetic protein-2-induced mineralization of osteoblasts via Smad-independent mechanisms.
    Takeno A; Kanazawa I; Notsu M; Tanaka KI; Sugimoto T
    Endocr J; 2018 Mar; 65(3):291-298. PubMed ID: 29249772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.